US trial for Cook's TAA (thoracic aortic aneurysms) graft
This article was originally published in Clinica
US researchers are investigating the use of the Cook Group's endovascular medical device for treating thoracic aortic aneurysms (TAA). Based at the Hospital of the University of Pennsylvania (HUP), the STARZ-TX2 trial will enrol 275 patients and include up to 35 institutions in the US and Canada.
You may also be interested in...
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.